Inventor
LERESTIF JEAN-MICHEL
FR13 patents
⚠️ This page may combine multiple inventors who share the name “LERESTIF JEAN-MICHEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SERVIER LAB
9 patentsUS7176197B2Feb 13, 2007
Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
SERVIER LAB17 citations91
US6982350B2Jan 3, 2006
Process for the synthesis of (1S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane and addition salts thereof, and to the application thereof in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
SERVIER LAB6 citations72
US7928223B2Apr 19, 2011
Process for the synthesis of 7,8-dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
SERVIER LAB2 citations61
US7867994B2Jan 11, 2011
Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
SERVIER LAB3 citations61
US7064200B2Jun 20, 2006
Process for the synthesis of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
SERVIER LAB6 citations61
US7074920B2Jul 11, 2006
Process for the synthesis of 1,3-dihydro-2H-3-benzazepin-2-one compounds, and to the application thereof in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
SERVIER LAB1 citations50
US8927758B2Jan 6, 2015
Process for the resolution of enantiomers of (3,4 dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl)nitrile and application in the synthesis of ivabradine
SERVIER LAB0 citations45
US8778930B2Jul 15, 2014
Process for the resolution of enantiomers of (3,4-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl)nitrile and application in the synthesis of ivabradine
SERVIER LAB0 citations45
US8952179B2Feb 10, 2015
Synthesis process, and crystalline form of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy} benzamide hydrochloride and pharmaceutical compositions containing it
SERVIER LAB0 citations43
PEGLION JEAN-LOUIS
2 patentsUS8415468B2Apr 9, 2013
Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
PEGLION JEAN-LOUIS2 citations60
US8097720B2Jan 17, 2012
Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
PEGLION JEAN-LOUIS4 citations60